ShareProphets : tidm

BME

B&M European Value Retail – Q1 trading statement emphasising “revenue growth of 2%”, how positive is that?…

“Variety retailer with 797 stores in the UK operating under the B&M brand, 340 stores under the Heron Foods and B&M Express brands, and 151 stores in France”, B&M European Value Retail (BME) has issued a ‘first quarter trading statement’ headlined “Group revenue growth of 2% driven by strong performance at B&M France”. Hmmm, how good is that?

By Steve Moore | Published 2026-07-15 09:43:52 |

B&M (#BME) – Q1 revenue +2% YoY, argues “confidence in rebuilding group profitability over time”

2026-07-15 06:57:59

B&M (#BME) – FY adj. EPS down to 21.3p, DPS to 9.6p, current year “a year of investment”

2026-06-03 06:42:29

B&M (#BME) – H1 adj. EPS down to 7.2p, DPS to 3.5p, argues its “Back to B&M Basics plan is progressing”

2025-11-13 07:47:09

B&M “Update on FY26 Guidance and Directorate Change” – a combination which doesn’t tend to bode well…

“Variety retailer with 786 stores in the UK operating under the B&M brand, 344 stores under the Heron Foods and B&M Express brands, and 140 stores in France”, B&M European Value Retail (BME) has issued an “Update on FY26 Guidance and Directorate Change” announcement – a combination which doesn’t tend to bode well…

By Steve Moore | Published 2025-10-20 10:14:46 |

B&M (#BME) – FY reduced outlook as “overseas freight costs not correctly recognised”, CFO Mike Schmidt “intention to step down”

2025-10-20 06:35:35

B&M (#BME) – trading warning, recently-appointed CEO Tjeerd Jegen argues “a decisive plan… focused on returning the UK business to sustainable like-for-like growth”

2025-10-07 06:25:40

B&M (#BME) – Q1 to 28th June “growth from new space and a positive quarterly LFL performance in B&M UK and B&M France”

2025-07-15 06:50:19

B&M (#BME) – FY adj. EPS -7% to 33.5p, DPS +2% to 15p, notes current year “retail sector-wide challenges”

2025-06-04 06:25:59

B&M (#BME) – appointment of Tjeerd Jegen as CEO from 16th June

2025-05-15 06:50:25

B&M (#BME) – FY adj. EBITDA “expected to be above the midpoint of our £605m-£625m guidance range”, notes CEO succession “progress”

2025-04-15 06:50:34

B&M (#BME) – profit warning and CEO Alex Russo “to retire” at end-April

2025-02-24 07:48:19

B&M (#BME) – Q3 to 28th Dec update notes growth but B&M UK LFL revenue -2.8%, declares 15p special DPS

2025-01-09 07:35:39

B&M (#BME) – H1 adj. EPS down to 14.7p, DPS up to 5.3p, “confident in our outlook for the second half”

2024-11-14 07:35:58

B&M (#BME) – Q1 revenue impacted by “unseasonal weather in April and May”

2024-07-16 06:23:48

B&M (#BME) – FY adj. EPS edged up to 36.8p and ordinary DPS to 14.7p, “remain confident in our outlook for cash generation and profit growth”

2024-06-05 06:25:48

B&M (#BME) – FY “volume growth led delivery at the top end of guidance”

2024-04-16 06:24:19

B&M (#BME) – Q3 revenue +5% YoY, 14 weeks to 30th Dec UK LFL revenue +1.2%

2024-01-09 07:43:42

B&M (#BME) – H1 adj. EPS +8%, DPS +2%, increases FY adj. EBITDA guidance

2023-11-09 07:32:51

B&M (#BME) – Q1 revenue +13.5% YoY, argues “well positioned” for FY

2023-06-29 06:26:25

previous 0 Page 1 of 3 (55 articles) next 20

Latest News

Show All

UPDATED: Lucian Miers & Jim Mellon are coming back to Sharestock in 2027: early bird tickets now on sale, event 15% sold out!

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

Evil Banksta weighs in on TekCapital after today’s spooftastic RNS

Good news travels fast but bad news….the case of Skinbiotherapeutics

Mothercare: the end is nigh, don’t blame Trump, I told y’all eons ago

EXPOSE: Nuburu shares in a slump post relisting on American Stock Exchange and latest accounts contain a material error

Letter to Pointon Young, former auditors to Amazing AI

Reinvesting my Satsuma Winnings

Tribal Group – “Proposed Acquisition by Main Capital Partners” provides us with another share tip winner

Quantum Data Energy - why are its shares still suspended?

Recent Comments

TOM18 Sep 2026

a shareholder could call a meeting to propose new directors by PM & pals own 50% of the equity sod vote it down

Letter to Pointon Young, former auditors to Amazing AI

AIMINVESTOR18 Sep 2026

This makes a mockery of the the so called rules and regulations when something as blatant as this is done.It's a shame a shareholder can't propose themselves as a director just to prevent the strike-off.Is there nothing legal that can be done at this point?

Letter to Pointon Young, former auditors to Amazing AI

TOYIN18 Sep 2026

Thanks Tom, just picked some more up sub 8p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

JOHN BROWN18 Sep 2026

It's outrageous that the likes of Amy Hunt claim that women with Sydney Sweeney's body shape cannot play sport. Who said that sportswomen can't look like Ms Sweeney?

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

MICKTHELINGE18 Sep 2026

If it gets to 3p then construction will be going well and it will be well on the way to 6p+ so interested in why you would sell out then?

Reinvesting my Satsuma Winnings

TOM18 Sep 2026

Whatever Opti's intentions it will have to sell.You could say you should sell now as maybe your last chance to sell at above 8oops too late, now 7.5p to sell

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

I thought that a seasoned reader of financial statements would have clocked that OPTI's HY results to 30/6/26 classed their SBTX shares as non-current assets – meaning that management has no intention to sell them within 12 months.Maybe you assumed that they were forced to class them as non-current because SBTX shares were suspended…but no, the SBTX suspension was lifted weeks before OPTI's sign-off date.And if you believe that OPTI haven't sold all or most of their remaining SBTX shares since June 30th, I'm afraid they saw you coming.There is of course a risk that OPTI has double accounted for its SBTX shares, having included them in both non-current assets and in "cash and equivalents", which might be a fruitful line of enquiry for you.As for Skin's RNS arriving a day outside the standard 10th-20th definition of mid-month, they have had a lot of balls to juggle so a 24hr delay ought to be a cause for congratulations.Why not grab some SBTX shares this afternoon? Could be your last chance to buy back below 12p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

Notwithstanding your ad nauseam negativity on SBTX, I choose to believe the positive indications from the 8 June RNS, including "Growth continued across the company", under Current Trading and Outlook (from a chairman who never speaks with forked tongue). Accordingly, I have helped myself to a nice top-up in anticipation of a welcome trading update on Monday.

Tom Winnifrith Bearcast: Hang on for the PS in the podcast

BOBINS18 Sep 2026

lets hope the Houthis keep away from the Saudi Mines?

Reinvesting my Satsuma Winnings

Charles18 Sep 2026

Easy work for the FCA with you having laid it out.

EXPOSE: Paul Mathieson and the strike off: you might think that, I could not comment